Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Expert Review of Anticancer Therapy|July 24, 2004
Current treatment options for endometrial cancerAlessandro D Santin, Stefania Bellone, Timothy J O'Brien, et al.
International Reviews of Immunology|May 12, 2011
Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapiesMaurizio Chiriva-Internati, Leonardo Mirandola, W Martin Kast, et al.
Cancer Immunology, Immunotherapy : CII|August 16, 2011
CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trendKevin H Kim, William W Greenfield, Martin J Cannon, et al.
International Reviews of Immunology|May 12, 2011
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancerLeonardo Mirandola, Martin J Cannon, Everardo Cobos, et al.
Qualitative Health Research|March 4, 2006
Body-related emotional experiences of young aboriginal womenTara-Leigh Fleming, Kent C Kowalski, M Louise Humbert, et al.
Expert Review of Anticancer Therapy|July 13, 2002
Novel target antigens for dendritic cell-based immunotherapy against ovarian cancerMartin J Cannon, Timothy J O'Brien, L Joey Underwood, et al.
The Prostate|April 27, 2011
Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancerMaurizio Chiriva-Internati, Yuefei Yu, Leonardo Mirandola, et al.
Gynecologic Oncology|October 8, 2003
Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapyStefania Bellone, Michela Palmieri, Murat Gokden, et al.
Gynecologic Oncology|May 21, 2005
High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancerStefania Bellone, Katherine Watts, Stefania Cane', et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2013
Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigenMartin J Cannon, Hannah E Goyne, Pamela J B Stone, et al.
Pageof 6